hi groins, I just watched Wayne’ interview and looks like the pivotal trial will be a prospective randomised trial hence the existing available valves will also be used in the trial. The bottomline is that the cost of the trial will be largely similar as the total number of implants for the trial will be more or less the same. We should get paid for the treatment of our valve used in the implant.
btw I am not sure about the how the breakthrough device status fits in. Also the trial will be non-inferiority trial and the requirement will be less comparing to superiority trials.
- Forums
- ASX - By Stock
- AVR
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-15
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.75 |
Change
-0.230(1.21%) |
Mkt cap ! $360.4M |
Open | High | Low | Value | Volume |
$19.00 | $19.00 | $18.52 | $179.2K | 9.566K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 109 | $18.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.75 | 999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 109 | 18.510 |
1 | 1000 | 18.500 |
1 | 50 | 18.400 |
2 | 302 | 18.250 |
1 | 50 | 18.200 |
Price($) | Vol. | No. |
---|---|---|
18.750 | 999 | 1 |
19.100 | 55 | 1 |
19.140 | 63 | 1 |
19.200 | 567 | 1 |
19.500 | 1230 | 1 |
Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
Last
$18.52 |
  |
Change
-0.230 ( 2.01 %) |
|||
Open | High | Low | Volume | ||
$18.52 | $18.52 | $18.52 | 14 | ||
Last updated 10.49am 30/05/2024 ? |
Featured News
AVR (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin & Ramón Jiménez Serrano, Managing Director & Executive Director
Ryan Parkin & Ramón Jiménez Serrano
Managing Director & Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online